Clinical Trial Update: Is Levosimendan Superior to Milrinone Regarding Acute Kidney Injury After Cardiac Surgery for Congenital Heart Disease? [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating whether levosimendan reduces acute kidney injury compared with milrinone after cardiac surgery in congenital heart disease pat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Defects

Drugs mentioned

• Levosimendan (levosimendan)
• Milrinone (milrinone)

Snippet

Sponsor: Göteborg University | Conditions: Congenital Heart Defects | Phase 2 | Status: COMPLETED | Results posted: 2024-03-26